Double-barreled CRISPR technology as a novel treatment strategy for COVID-19

DA Nalawansha… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus is one of the causative agents for multiple human respiratory illnesses. A novel
coronavirus, similar to the one that caused severe acute respiratory syndrome (SARS) in …

Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19

DA Nalawansha… - ACS pharmacology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Coronavirus is one of the causative agents for multiple human respiratory illnesses. A novel
coronavirus, similar to the one that caused severe acute respiratory syndrome (SARS) in …

[HTML][HTML] Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19

DA Nalawansha, KTG Samarasinghe - ACS Pharmacology & …, 2020 - ncbi.nlm.nih.gov
Coronavirus is one of the causative agents for multiple human respiratory illnesses. A novel
coronavirus, similar to the one that caused severe acute respiratory syndrome (SARS) in …

Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19.

DA Nalawansha, KTG Samarasinghe - ACS Pharmacology & …, 2020 - europepmc.org
Coronavirus is one of the causative agents for multiple human respiratory illnesses. A novel
coronavirus, similar to the one that caused severe acute respiratory syndrome (SARS) in …

[PDF][PDF] Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19

2020 - researchgate.net
Coronavirus is one of the causative agents for multiple human respiratory illnesses. A novel
coronavirus, similar to the one that caused severe acute respiratory syndrome (SARS) in …